
Duke-NUS in Singapore partners with Swedish biotech startup Alder Therapeutics
This will enhance the development of Alder’s retinal and cardiac cell therapeutic products In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related patents to Sweden-based biotech startup …